In situ expression of yak DEFB127 via plasmid-mediated delivery alleviates bovine Staphylococcus aureus-induced mastitis through anti-inflammatory mechanisms
- 1College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu, Sichuan, China
- 2Sichuan Academy of Grassland Science, Chengdu, Sichuan, China
Abstract
Introduction: Mastitis, a disease affecting milk production and quality, poses a significant challenge to agricultural practitioners. Conventional antibiotic treatments present potential issues such as drug resistance, disruption of animal intestinal microbiota, and milk safety issues, necessitating the development of novel alternative therapies for bovine mastitis. Yak β-defensin 127 (DEFB127), a natural antimicrobial peptide, represents a promising candidate for alternative to antibiotics, yet remains underexplored as a therapy for mastitis.
Results: In MAC-T cell, qRT-PCR analysis revealed that expression of IL-6 and IL-1β in the pLF-DEFB127 treatment group were significantly lower than the infection group (P < 0.01). In vivo, histopathological examination showed that degree of inflammatory cell infiltration in the mammary gland tissue of the treatment group was significantly reduced compared to the infection group, accompanied by marked alleviation of alveolar dilation and epithelial cell necrosis. ELISA and qRT-PCR results demonstrated that the expression of TNF-α, IL-6, and IL-1β in the mammary gland tissue of mice from the pLF-DEFB127 treatment group were significantly downregulated than those in the infection group (P < 0.01). Furthermore, 16S rRNA gene sequencing revealed that pLF-DEFB127 treatment altered the structure of the mouse intestinal microbiota, increasing the relative abundance of Bacteroidia and Bacilli, while decreasing that of Gammaproteobacteria. Finally, functional prediction of the intestinal microbiota based on 16S rRNA correlation analysis indicated that yak DEFB127 might exert anti-inflammatory effects by mechanisms involving glycosphingolipid biosynthesis and immune signaling, though this requires experimental validation.
Related
- Uhrf1‐Mediated PKM2 Degradation via Ubiquitination Alleviates Inflammation and Pyroptosis in Inflammatory Bowel Disease
- Gut–Brain Axis-Mediated Neurological Manifestations in Inflammatory Bowel Disease: Mechanisms and Disease Spectrum
- Integrative Analysis of Whole Exome Sequencing and Gene Expression to Uncover Genetic Mechanisms in Inflammatory Bowel Disease.
- A cis-encoded RNA interaction controls sub-operonic spoVG expression in Staphylococcus aureus
- Disulfiram alleviates inflammatory pain by suppressing TLR4/NF-κB signaling in sensory ganglia
BibTeX
@article{lu2026situ,
title = {{In situ expression of yak DEFB127 via plasmid-mediated delivery alleviates bovine Staphylococcus aureus-induced mastitis through anti-inflammatory mechanisms}},
author = {Dizhi Lu and Zening Wang and Wenying Dai and Ze Zhou and Shujun Yue and Xiangfei Zhang and Biao Li and Mingfeng Jiang and Yili Liu},
journal = {Frontiers in Veterinary Science},
year = {2026},
month = oct,
doi = {10.3389/fvets.2026.1910975},
url = {https://doi.org/10.3389/fvets.2026.1910975},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In situ expression of yak DEFB127 via plasmid-mediated delivery alleviates bovine Staphylococcus aureus-induced mastitis through anti-inflammatory mechanisms
AU - Dizhi Lu
AU - Zening Wang
AU - Wenying Dai
AU - Ze Zhou
AU - Shujun Yue
AU - Xiangfei Zhang
AU - Biao Li
AU - Mingfeng Jiang
AU - Yili Liu
PY - 2026
DA - 2026/10/22
JO - Frontiers in Veterinary Science
DO - 10.3389/fvets.2026.1910975
UR - https://doi.org/10.3389/fvets.2026.1910975
AB - Introduction: Mastitis, a disease affecting milk production and quality, poses a significant challenge to agricultural practitioners. Conventional antibiotic treatments present potential issues such as drug resistance, disruption of animal intestinal microbiota, and milk safety issues, necessitating the development of novel alternative therapies for bovine mastitis. Yak β-defensin 127 (DEFB127), a natural antimicrobial peptide, represents a promising candidate for alternative to antibiotics, yet remains underexplored as a therapy for mastitis. Results: In MAC-T cell, qRT-PCR analysis revealed that expression of IL-6 and IL-1β in the pLF-DEFB127 treatment group were significantly lower than the infection group (P < 0.01). In vivo, histopathological examination showed that degree of inflammatory cell infiltration in the mammary gland tissue of the treatment group was significantly reduced compared to the infection group, accompanied by marked alleviation of alveolar dilation and epithelial cell necrosis. ELISA and qRT-PCR results demonstrated that the expression of TNF-α, IL-6, and IL-1β in the mammary gland tissue of mice from the pLF-DEFB127 treatment group were significantly downregulated than those in the infection group (P < 0.01). Furthermore, 16S rRNA gene sequencing revealed that pLF-DEFB127 treatment altered the structure of the mouse intestinal microbiota, increasing the relative abundance of Bacteroidia and Bacilli, while decreasing that of Gammaproteobacteria. Finally, functional prediction of the intestinal microbiota based on 16S rRNA correlation analysis indicated that yak DEFB127 might exert anti-inflammatory effects by mechanisms involving glycosphingolipid biosynthesis and immune signaling, though this requires experimental validation.
SN - 2297-1769
ER -